MGG-backed Sightpath Medical completed the acquisition of PennVista.

MGG-backed Sightpath Medical, an ophthalmic equipment and services provider, completed the acquisition of PennVista, a refractive ophthalmologic solutions and cataract surgery provider. Financial terms were not disclosed. "The integration of PennVista into Sightpath Medical marks a significant milestone in our mission to support ophthalmology practices. This transaction, coupled with our recent LASIK Doctor Network Project, underscores our commitment to helping comprehensive ophthalmology practices successfully offer LASIK to their patients. By combining our resources and expertise, we can deliver exceptional services and innovative solutions that meet the evolving needs of our partners," Joel Gaslin, Sightpath Medical President and CEO.